JNBA Financial Advisors’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $163 | Hold |
210
| – | – | ﹤0.01% | 645 |
|
|
2025
Q1 | $116 | Hold |
210
| – | – | ﹤0.01% | 643 |
|
|
2024
Q4 | $192 | Hold |
210
| – | – | ﹤0.01% | 640 |
|
|
2024
Q3 | $183 | Hold |
210
| – | – | ﹤0.01% | 644 |
|
|
2024
Q2 | $208 | Hold |
210
| – | – | ﹤0.01% | 630 |
|
|
2024
Q1 | $223 | Hold |
210
| – | – | ﹤0.01% | 658 |
|
|
2023
Q4 | $284 | Hold |
210
| – | – | ﹤0.01% | 689 |
|
|
2023
Q3 | $458 | Hold |
210
| – | – | ﹤0.01% | 708 |
|
|
2023
Q2 | $546 | Hold |
210
| – | – | ﹤0.01% | 684 |
|
|
2023
Q1 | $252 | Hold |
210
| – | – | ﹤0.01% | 707 |
|
|
2022
Q4 | $342 | Hold |
210
| – | – | ﹤0.01% | 640 |
|
|
2022
Q3 | $0 | Hold |
210
| – | – | ﹤0.01% | 735 |
|
|
2022
Q2 | $0 | Hold |
210
| – | – | ﹤0.01% | 742 |
|
|
2022
Q1 | $0 | Hold |
210
| – | – | ﹤0.01% | 796 |
|
|
2021
Q4 | $0 | Hold |
210
| – | – | ﹤0.01% | 859 |
|
|
2021
Q3 | $0 | Hold |
210
| – | – | ﹤0.01% | 747 |
|
|
2021
Q2 | $1K | Hold |
210
| – | – | ﹤0.01% | 660 |
|
|
2021
Q1 | $1K | Hold |
210
| – | – | ﹤0.01% | 629 |
|
|
2020
Q4 | $0 | Hold |
210
| – | – | ﹤0.01% | 629 |
|
|
2020
Q3 | $0 | Hold |
210
| – | – | ﹤0.01% | 584 |
|
|
2020
Q2 | $0 | Hold |
210
| – | – | ﹤0.01% | 579 |
|
|
2020
Q1 | $0 | Hold |
210
| – | – | ﹤0.01% | 601 |
|
|
2019
Q4 | $1K | Hold |
210
| – | – | ﹤0.01% | 587 |
|
|
2019
Q3 | $0 | Hold |
210
| – | – | ﹤0.01% | 669 |
|
|
2019
Q2 | $0 | Hold |
210
| – | – | ﹤0.01% | 691 |
|
|
2019
Q1 | $0 | Hold |
210
| – | – | ﹤0.01% | 559 |
|
|
2018
Q4 | $0 | Buy |
+210
| New | – | ﹤0.01% | 674 |
|
|
2018
Q3 | – | Sell |
-210
| Closed | -$1K | – | 640 |
|
|
2018
Q2 | $1K | Buy |
+210
| New | +$1K | ﹤0.01% | 517 |
|